Tests zur Detektion einer Infektion mit SARS-CoV-2 (neuartiges Coronavirus) sowie zum Nachweis von Antikörpern gehören zu den sog. In-vitro-Diagnostika (IVD). Das erstmalige Inverkehrbringen von In-vitro-Diagnostika auf dem deutschen Markt ist nach §§ 25 und 30 Medizinproduktegesetz (MPG) anzeig...epflichtig. Das DIMDI betreibt dafür die Datenbank "In-vitro-Diagnostika-Anzeigen (MPIVDA)", in welcher demnach auch Daten von "Corona-Tests" von den anzeigepflichtigen deutschen Herstellern und Bevollmächtigten bzw. Einführern erfasst werden.
more
The key objective is to celebrate, source, and supply innovations across 12 COVID-19 categories (i.e. response areas). The growing list of 800+ featured innovations includes those that are ready to deploy, plus innovations that could be adapted for COVID-19 responses, or inspire new, much-needed sol...utions. A smaller list is identified as COVID-19 Recognized Innovations for their response efforts so others can more easily find and use them. We are also actively sourcing new innovations designed in response to COVID-19. We hope you find it valuable as we come together to address this global challenge, and would welcome your support so we can continue to help use innovation in tackling future crises yet to come.
more
Solidarity” is an international clinical trial to help find an effective treatment for COVID-19, launched by the World Health Organization and partners.
The Solidarity Trial will compare four treatment options against standard of care, to assess their relative effectiveness against COVID-19. By... enrolling patients in multiple countries, the Solidarity Trial aims to rapidly discover whether any of the drugs slow disease progression or improve survival. Other drugs can be added based on emerging evidence.
Until there is sufficient evidence, WHO cautions against physicians and medical associations recommending or administering these unproven treatments to patients with COVID-19 or people self-medicating with them. WHO is concerned by reports of individuals self-medicating with chloroquine and causing themselves serious harm.
more
A lot of research articles concerning SARS-CoV-2/COVID-19 are published every day. Many of them, so-called pre-prints, are not reviewed in a professional reviewing process at the time of publication. Others are already reviewed and published in well-known journals. Collabovid helps researchers to id...entify the most relevant information by using Natural Language Processing. You can search for any topic you want below. Visit search to review all articles or browse a list of predefined categories. For additional help visit the frequently asked questions.
more
FIND is collating an overview of SARS-CoV-2 tests that are commercially available or in development for the diagnosis of COVID-19. We do not guarantee that this is a comprehensive list, since the information below has been submitted voluntarily by test suppliers and is not independently verified. Pl...ease find the latest lists on the website
more
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications about SARS-CoV-2 and COVID-19. Many papers discussed in the Top 10 will eventually make it into subsequent editions of COVID Reference.
Almost all organizations recommend masks for the general public. Unfortunately, earlier in the pandemic, many did exactly the opposite – due to limited data but also due to concerns about diminished mask supply for healthcare workers and out of fear that masked individuals might be tempted to igno...re rules of social distancing. In addition, conflicting national guidelines have led to variable public compliance. A few physicians, in line with some COVidiots, still argue against face masks
more
Every day – Monday, Tuesday, Wednesday, Thursday, Friday, Saturday, Sunday – they present the Top 10 scientific COVID-19 papers of the day. The daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications about SARS-CoV-2 and COVID-19
A Organização Mundial da Saúde (OMS) convida seus Estados Membros, serviços de saúde e outras entidades para contribuírem com a OMS na vigilância de dados clínicos de casos de pacientes hospitalizados com COVID-19, a fim de melhorar o entendimento global sobre a apresentação clínica dessa... doença. A análise de dados clínicos padronizados e anônimos do mundo todo é essencial para o desenvolvimento de diretrizes baseadas em evidências para o manejo clínico da COVID-19 e para subsidiar respostas de saúde pública.
more
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications about SARS-CoV-2 and COVID-19. Many papers discussed in the Top 10 will eventually make it into subsequent editions of COVID Reference.
As of 31 October 2020 This is the tenth edition of this summary of rapid systematic reviews, which includes the results of a rapid systematic review of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. I...n this review, 46 therapeutic options are examined. The Pan American Health Organization (PAHO) is continually monitoring ongoing research on any possible therapeutic options. As evidence emerges, then PAHO will immediately assess and update its position, and particularly as it applies to any special sub-group populations such as children, expectant mothers, those with immune conditions, etc.
more
Методические рекомендации «Правила работы нейрохирургических отделений при подозрении на новую коронавирусную инфекцию COVID-19», Методические рекомендации «Анест...езиолого-реанимационное обеспечение пациентов с новой коронавирусной инфекцией COVID-19. Версия 4», Временные методические рекомендации «Болезни органов пищеварения в условиях пандемии новой коронавирусной инфекции (COVID-19)» и т.д.
more
Вебинары ФГБУ «НМИЦ ФПИ» Минздрава России для медицинских работников в связи с угрозой распространения нового коронавируса COVID-19
doi: https://doi.org/10.1101/2020.10.28.20221143
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.